Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement

Eriksson, B. I., Kakkar, A. K., Turpie, A. G. G., Gent, M., Bandel, T.-J., Homering, M., Misselwitz, F., Lassen, M. R. · 2009 · The Journal of Bone and Joint Surgery. British volume

Abstract

A once-daily dose of rivaroxaban 10 mg, an oral, direct Factor Xa inhibitor, was compared with enoxaparin 40 mg subcutaneously once daily for prevention of venous thromboembolism in three studies of patients undergoing elective hip and knee replacement (RECORD programme). A pooled analysis of data from these studies (n = 9581) showed that rivaroxaban was more effective than enoxaparin in reducing the incidence of the composite of symptomatic venous thromboembolism and all-cause mortality at two weeks (0.4% vs 0.8%, respectively, odds ratio 0.44; 95% confidence interval 0.23 to 0.79; p = 0.005), and at the end of the planned medication period (0.5% vs 1.3%, respectively; odds ratio 0.38; 95% confidence interval 0.22 to 0.62; p < 0.001). The rate of major bleeding was similar at two weeks (0.2% for both) and at the end of the planned medication period (0.3% vs 0.2%). Rivaroxaban started six to eight hours after surgery was more effective than enoxaparin started the previous evening in preventing symptomatic venous thromboembolism and all-cause mortality, without increasing major bleeding.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1302/0301-620x.91b5.21691

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 177

Metadata

Authors
Eriksson, B. I., Kakkar, A. K., Turpie, A. G. G., Gent, M., Bandel, T.-J., Homering, M., Misselwitz, F., & Lassen, M. R.
Venue
The Journal of Bone and Joint Surgery. British volume
Published
2009-05
Volume
91-B
Issue
5
Pages
636-644
ISSN
  • 0301-620X (ISSN-L)
  • 2044-5377
OpenAlex
W2154183176
Cited by
177
References
2
FWCI
17.24
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. https://app.cochat.ai/papers/10.1302/0301-620x.91b5.21691
The paper
Eriksson, B. I., Kakkar, A. K., Turpie, A. G. G., Gent, M., Bandel, T.-J., Homering, M., Misselwitz, F., & Lassen, M. R. (2009). Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. The Journal of Bone and Joint Surgery. British volume. https://doi.org/10.1302/0301-620x.91b5.21691

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.